← Back to Analyst Consensus 
CRBG Buy
Corebridge Financial, Inc.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 6 reiterations from 6 firms
Next Earnings
Nov 2, 2026 (6 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Oct 12, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Oct 7, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Oct 6, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 20, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 19, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 12, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 11, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Jul 22, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 15, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jul 13, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 13, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Jul 10, 2026 | Jefferies | maintain | Buy → Buy | — | 52% |
| Jul 9, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 9, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 8, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 26, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 12, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| May 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 7, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 6, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Apr 28, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 14, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 10, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Apr 10, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 11, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 10, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Mar 3, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 25, 2026 | Wells Fargo | maintain | Overweight → Overweight | $36 | 54% |
| Feb 10, 2026 | Barclays | maintain | Overweight → Overweight | $34 | 53% |
| Feb 10, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $37 | 58% |
| Jan 13, 2026 | Wells Fargo | maintain | Overweight → Overweight | $37 | 54% |
| Jan 8, 2026 | Barclays | maintain | Overweight → Overweight | $35 | 53% |
| Jan 8, 2026 | UBS | maintain | Neutral → Neutral | $33 | 54% |
| Jan 5, 2026 | JP Morgan | maintain | Neutral → Neutral | $39 | 55% |
| Dec 16, 2025 | Mizuho | initiate | — → Outperform | $38 | 52% |
| Nov 17, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $33 | 54% |
| Nov 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $43 | 54% |
| Nov 5, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $37 | 58% |
| Oct 10, 2025 | Wolfe Research | initiate | — → Peer Perform | $0 | 54% |
| Oct 9, 2025 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | $41 | 58% |
| Oct 9, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $38 | 58% |
| Oct 8, 2025 | Barclays | maintain | Overweight → Overweight | $39 | 53% |
| Oct 8, 2025 | Wells Fargo | maintain | Overweight → Overweight | $44 | 54% |
| Oct 7, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $39 | 54% |
Price Target Trend
Jul 18, 2026 Latest: $40.42 Oct 26, 2026
EPS Estimates
0y $4.56
Lo: $4.29 Hi: $4.73
16 analysts ▲3
+1q $1.15
Lo: $1.03 Hi: $1.28
13 analysts ▲3
+1y $5.73
Lo: $5.12 Hi: $5.94
16 analysts ▲2
0q $1.24
Lo: $1.10 Hi: $1.36
15 analysts ▲5
Cross-Platform Signals
No cross-platform signals in the last 90 days